News & Events


Meet Our New CEO Steve Powell!

Meet Our New CEO Steve Powell!
18 July 2017

Synteract is pleased to announce that Steve Powell has been appointed as our new Chief Executive Officer. Mr. Powell has more than 25 years of executive leadership experience in both the CRO and pharma/biotech industries.  Drawing on this strong base of expertise, he will direct the overall company strategy, positioning, processes and performance.

An industry veteran with 26 years of experience in all facets of Phase I-IV clinical research, Steve will bring to Synteract guidance on many of the best practices and technologies that he has gained over the course of his career. Steve will be instrumental in expanding Synteract’s services and furthering our geographic reach to best serve our innovative pharma and biotech customers.

Prior to joining Synteract, Steve was Executive Vice President at ERT, having come to ERT through its acquisition of Exco InTouch in December 2016.  As EVP at ERT, Steve managed all aspects of operational delivery and technology development. Prior to Exco InTouch/ERT, Mr. Powell served as Executive Vice President, Clinical Informatics and Late Phase Services at PRA Health Sciences for over eight years where he was instrumental in that company’s global expansion from 2,000 to more than 10,000 employees.  Prior to joining PRA in 2006, he held several leadership positions across the health care, technology and CRO industries.

Steve brings a team-oriented approach to leadership, an extensive mix of both operational and industry knowledge, and a keen focus on customer service.  We are confident that Steve will help us reach our goal to becoming the best, highest quality CRO serving innovative biotech and pharma customers.

Welcome to the Synteract team, Steve!


Contact Synteract

Tell us how to stay in touch with you: